The mTORC1 inhibitor everolimus prevents and treats E?-Myc lymphoma by restoring oncogene-induced senescence
Wall, Meaghan; Poortinga, Gretchen; Stanley, Kym L.; Lindemann, Ralph K.; Bots, Michael; Chan, Christopher J; Bywater, Megan J.; Kinross, Kathryn M.; Astle, Megan V.; Waldeck, Kelly; Hannan, Katherine; Shortt, Jake; Smyth, Mark J; Lowe, Scott W.; Hannan, Ross; Pearson, Richard B; Johnstone, Ricky; McArthur, Grant
MYC deregulation is common in human cancer. IG-MYC translocations that are modeled in EμMyc mice occur in almost all cases of Burkitt lymphoma as well as in other B-cell lymphoproliferative disorders. Deregulated expression of MYC results in increased mT
|Collections||ANU Research Publications|
|01_Wall_The_mTORC1_inhibitor_2013.pdf||8.75 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.